MIAMI, FL -- (MARKET WIRE) -- February 09, 2007 -- DOR BioPharma, Inc. (“DOR” or the “Company”) (OTCBB: DORB) announced that it has completed the sale of common stock in a private placement to institutional investors as well as members of DOR’s senior management and Board of Directors. DOR received gross proceeds of approximately $5.5 million.
